<DOC>
	<DOCNO>NCT03097432</DOCNO>
	<brief_summary>This prospective open multi-centre non-interventional study initiate document up-dosing period child adult allergic rhinoconjunctivitis and/or allergic asthma treat SLIT contain purify , aqueous extract birch , alder , hazel pollen . The following up-dosing scheme freely selectable : scheme A consist up-dosing period 12 day patient´s home use standardized pollen extract three different solution strength reach maximum dose ; scheme B perform high solution strength physician 's office within 2 hour ; new scheme C regimen initiation physician ` office continuation patient ` home also exclusively use high solution strength take 4 day . Data document physician patients´ diary .</brief_summary>
	<brief_title>Non-interventional Study Assess Tolerability , Safety Profile Adherence Different Up-dosing Schemes Sublingual Immunotherapy Treatment</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<criteria>Patients age 2 year old suffer tree pollen induce seasonal allergic rhinitis Patients suffer acute chronic infection inflammation Patients suffer secondary modification target organ function impairment ( emphysema , bronchiectasis ) Patients suffer severe uncontrolled asthma Patients know severe autoimmune disease Patients active malignant disease Patients require betablockers Patients contraindication use adrenaline Patients hypersensitivity excipients drug</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>